{"id":211021,"date":"2019-09-21T14:45:02","date_gmt":"2019-09-21T19:45:02","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=211021"},"modified":"2021-04-18T21:19:26","modified_gmt":"2021-04-19T02:19:26","slug":"save-moms-babies-fda-safeguards-abortion-pill","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/save-moms-babies-fda-safeguards-abortion-pill\/","title":{"rendered":"‘SAVE Moms & Babies Act’ introduced in House to keep FDA abortion pill safeguards in place"},"content":{"rendered":"
<\/div>

A new bill introduced in the U.S. House of Representatives would prevent the FDA from loosening important safety restrictions (known as REMS) for the abortion pill (mifepristone). According to a press release<\/a>\u00a0from the office of\u00a0Rep. Robert E. Latta<\/a> (R-OH), the\u00a0Support and Value Expectant (SAVE) Moms & Babies Act<\/a>, legislation addresses “many of the concerns surrounding chemical abortion pills. The SAVE Moms & Babies Act would prevent labeling changes for already approved abortion drugs; prevent providers from dispensing these drugs remotely, by mail, or via tele-medicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.” The release continues:<\/p>\n

Currently, the chemical abortion pill, Mifeprex, has a Risk Evaluation and Mitigation Strategies (REMS) label on it, indicating it is a dangerous drug with known serious risks. Chemical abortions, when compared to surgical abortions, have a higher complication rate and result in a higher rate of emergency room visits. If REMS is removed, patients won\u2019t need ultrasound\u00a0or medical examination before receiving this drug, and a single health care provider could mail out chemical abortion pills to women and young girls across the country, bypassing protections like parental involvement, waiting periods, and informed consent.<\/em><\/p>\n

\"Image:

Rep. Bob Latta tweets pro-life legislation to enforce FDA REMS on abortion pill<\/p><\/div>\n

The abortion pill, Mifeprex (mifepristone), was approved in 2000 after being brought to the U.S. by the eugenics-founded\u00a0Population Council,<\/a>\u00a0and was\u00a0funded<\/a>\u00a0by the Packard Foundation and other pro-abortion philanthropy groups. A highly secretive company<\/a>\u00a0— DANCO Laboratories — was set up to manufacture the drug.<\/p>\n

\"Image:

Packard Timeline shows it invested in abortion pill distributor<\/p><\/div>\n

Live Action News has been reporting on the abortion industry’s increased effort to expand abortion via online<\/a> TelAbortion<\/a>, pharmacy dispensing<\/a>\u00a0in pharmacy<\/a>\u00a0and mail order pharmacy<\/a>, and even dangerous and illegal distribution<\/a> of abortion pills online under so-called “self-managed<\/a>” abortion.\u00a0Live Action News has\u00a0documented<\/a>\u00a0that the\u00a0Buffett<\/a>\u00a0and\u00a0Packard<\/a>\u00a0Foundations were original investors in DANCO Labs. Billionaire\u00a0George Soros<\/a>\u00a0(Open Society Foundations)\u00a0and the California-based\u00a0Kaiser Family Foundation<\/a>\u00a0also invested in the abortion pill. Multiple studies<\/a> claiming that the off-label dispensing<\/a> of these pills is safe<\/a>\u00a0are often funded<\/a> by original investors in abortion pill manufacturer\u00a0DANCO<\/a>\u00a0— many of which fail<\/a> to reveal<\/a> these conflicts of interest.<\/p>\n

Live Action News has previously documented the following clinical trials, which are being conducted to expand the abortion pill’s availability and distribution:<\/p>\n

    \n
  • Direct-To-Consumer<\/a> (pills sent via mail after TelAbortion<\/a> or Telemedicine interview) here<\/a>.<\/li>\n
  • Pharmacy Dispensing<\/a> here<\/a>. Online Pharmacy dispensing here<\/a>.<\/li>\n
  • Non-pregnant women<\/a>\u00a0(since withdrawn<\/a>).<\/li>\n
  • Study to discredit Abortion Pill Reversal<\/a>\u00a0(now suspended<\/a>).<\/li>\n
  • Menstrual Regulation<\/a> study here<\/a>.<\/li>\n
  • Second trimester experiments in Africa here<\/a>.<\/li>\n<\/ul>\n

    On April 11, 2019, the FDA\u00a0approved<\/a>\u00a0a generic version of the pill regimen. As previously<\/a> documented, GenBioPro, Inc.\u2019s abbreviated new drug application was approved for a generic Mifeprex, which, when used with Misoprostol, is approved as an abortion pill regimen. This past week, the state of California approved legislation (SB24) which would require state universities and college campuses to dispense the abortion pill regimen on campus, despite the fact that expanding abortion pill access to young girls is not only dangerous but has a profit motive (read those connections here<\/a>).<\/p>\n